Beta Drugs Ltd

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE351Y01019
  • NSEID: BETA
  • BSEID:
INR
1,164.70
-37.3 (-3.1%)
BSENSE

Mar 27

BSE+NSE Vol: 14043

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1002857,
    "name": "Beta Drugs Ltd",
    "stock_name": "Beta Drugs Ltd",
    "full_name": "Beta Drugs Ltd",
    "name_url": "stocks-analysis/beta-drugs",
    "exchange": 1,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "1,164.70",
    "chg": -37.3,
    "chgp": "-3.1%",
    "dir": -1,
    "prev_price": "1,202.00",
    "mcapval": "1,196.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "BETA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE351Y01019",
    "curr_date": "Mar 27",
    "curr_time": "",
    "bse_nse_vol": 14043,
    "exc_status": "Active",
    "traded_date": "Mar 27, 2026",
    "traded_date_str": "2026 03 27",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/beta-drugs-1002857-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Why is Beta Drugs Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-beta-drugs-ltd-fallingrising-3877620",
        "imagepath": "",
        "date": "2026-03-07 01:04:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Short-Term Price Movement and Market Context</strong></p>\n<p>Beta Drugs Ltd's share price increase of ₹30.20 on 06-Mar represents a significant outperformance compared to its sector peers, with the stock rising 2.81% more than the sector average on the same day. This suggests that investors are showing a preference for Beta Drugs amid broader market fluctuations. Over the past week, the stock has gained 4.41%, contrasting sharply with the Sensex's decline of 2.89% during the same period. This divergence indicates that Beta Drugs is currently attracting buying interest even as the broader market faces headwinds.</p>\n<p>However, it is important to note that the stock's performance over longer horizons remains subdued. Year-to-date, Beta Drugs has declined by 29.12%, significantly underperformi..."
      }
    ],
    "total": 62,
    "sid": "1002857",
    "stock_news_url": "https://www.marketsmojo.com/news/beta-drugs-1002857"
  },
  "announcements": [
    {
      "details": "Beta Drugs Limited has informed the Exchange regarding 'International Plant Approvals'.",
      "source": "NSE",
      "caption": "Beta Drugs Limited - Updates",
      "datetime": "15-Nov-2019"
    },
    {
      "details": "Beta Drugs Limitedgs Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Beta Drugs Limited - Reply to Clarification- Financial results",
      "datetime": "14-Nov-2019"
    },
    {
      "details": "Beta Drugs Limiteded for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.",
      "source": "NSE",
      "caption": "Beta Drugs Limited - Clarification - Financial Results",
      "datetime": "08-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Beta Drugs Ltd has announced <strong>1:20</strong> bonus issue, ex-date: 26 Mar 25",
          "dt": "2025-03-26",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}
stock-recommendationAnnouncement

Beta Drugs Limited - Updates

15-Nov-2019 | Source : NSE

Beta Drugs Limited has informed the Exchange regarding 'International Plant Approvals'.

Beta Drugs Limited - Reply to Clarification- Financial results

14-Nov-2019 | Source : NSE

Beta Drugs Limitedgs Limited for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Beta Drugs Limited - Clarification - Financial Results

08-Nov-2019 | Source : NSE

Beta Drugs Limiteded for the quarter ended 30-Sep-2019 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

stock-recommendationCorporate Actions
Corporate Actions
info
stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

Beta Drugs Ltd has announced 1:20 bonus issue, ex-date: 26 Mar 25

stock-summary
RIGHTS

No Rights history available